{"name":"Ascendis Pharma Endocrinology Division A/S","slug":"ascendis-pharma-endocrinology-division-a-s","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOWjBQeWJ4OHgtVlVrMmhMTGd6OGQ2QVZnbHdHT21ISm01SzF5ZVdGNHlPemtWZ3Jzbm1JcnJZam1hQ2JqZUNySDByVzlvaXkzS3ZBZlpubloxX3hQbllVeEl6TENrWGRTclpoUUw5bUJXdncyRDhoSEZ5R1Q3TVJxMl96RjFDZ3A0?oc=5","date":"2026-04-05","type":"pipeline","source":"Defense World","summary":"Growth Stocks To Watch Now – April 3rd - Defense World","headline":"Growth Stocks To Watch Now – April 3rd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPU01mTUhmUWM3ZDdrMDB6Nko4b2dxVUphbXdpTC1xb0dJWnpzbzdLaGVlUGhsWHd5VjVWNFV5OXFSTTFKaFNiT292dDQ2VnlTcjROTWFYWURkVFFCV2NzMVRzQzcwUHVNQnZ4UUtOUkt2S3NxX1Y3NF9nRXdZU0Z6TndLOTlPMnRNR0FYcnJfd2F6UE54RVVReg?oc=5","date":"2026-04-04","type":"pipeline","source":"Defense World","summary":"Promising Growth Stocks To Watch Today – April 2nd - Defense World","headline":"Promising Growth Stocks To Watch Today – April 2nd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPMjFpRUNjQU1BMFdjS1B3a3lVcHhZb2FFRm0yeUlrMVF3ZmxfNXhLeDAzbUc1U1M5U2VCT2FrNGt6QUVjYUViamllbGY0VVh3UmtGV3Q1TDctd0xSX2J2VDZPTmZZU0o1MnBJazNrdGplY1V1SDNKU3ZWd1J1aVFlMktGWG9XVVZLeUw4c3BqaTlEOWl5NEFMdy1wem1jTk1pTG5CVFNmYWtfYTBlYXJhV0E4Z0VPQ3FDTHlr?oc=5","date":"2026-02-27","type":"regulatory","source":"Stock Titan","summary":"FDA approves once-weekly growth drug for children with achondroplasia - Stock Titan","headline":"FDA approves once-weekly growth drug for children with achondroplasia","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOXFMWnF1a2lnMGdIMGZkWmpzNm9Jd2U1MzR4aEFXX2dKVlBIMUlUTlVkWms1ZURPSldfc2tBWk5IUkNNbUNwVTl2MVJ1LWEyRnZRTjd6a0VJT3JNenk1Vno3WkJtaHg0NEZqQ1o4MU9TQVA2bEtpVmhzMzJLcFVKYldxS3RraEFvOEFGV0VudWZfcGppOXBWNWhzNmZlMzBrajFrRGQ0YS04b1Z4akd4OG95OGp1WExpQzRQcmMwNVVWUQ?oc=5","date":"2024-09-17","type":"regulatory","source":"Healio","summary":"Oral achondroplasia therapy receives FDA breakthrough therapy designation - Healio","headline":"Oral achondroplasia therapy receives FDA breakthrough therapy designation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPNFR6ZFdjOU5PdnNidjY2YmJqS2FyVHZmTzg5MzJzbnhib3pVelZhMjhoc0RJMHpTaXNZRzlva0xLM2wxNWVQemZselhaZW9RckF6VldEeUlkMEFJX0JEaGl2VXBHcFVQLWtkU0dzU0sxbWRJcWVBY3QtSlBoUjRPQ3VBLURmdnRIQW9XNGN1SE1yY2ZRU2JDeXVUMGhPWGx2VG55SE1SZmpXRXJwWWZpa2NSOFF5cGtlNHZidTlPU1MwYWNma3o4MkhVdTZUVEpsR1E?oc=5","date":"2024-07-29","type":"earnings","source":"Seeking Alpha","summary":"Weaker USD, Revenue Growth, And TransCon Technology Make Ascendis Pharma A Strong Buy Opportunity - Seeking Alpha","headline":"Weaker USD, Revenue Growth, And TransCon Technology Make Ascendis Pharma A Strong Buy Opportunity","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBMR2NhaE1Db3JVbUwzdEFSdXpMeEs3Ti1MdlQ0VFdkcklSc2Z3X1ZWOVFRNndKalVxWTVPYTlQbnlIRklLVGEzalBZdTY1T0NkM2pIdDdmUEIwYUF0aDdjUWZ0bF9mdnNKOHc?oc=5","date":"2022-10-21","type":"trial","source":"Wiley Online Library","summary":"Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial - Wiley Online Library","headline":"Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNQmU5eFpTaXJ3MU11MG5PT0tYOHZVR3ZfaWlyQ21RSXQwUkQtaFZnZU5LVVNFZnlhOFROOThadWtVZFZCYmFaZW9sUktmVXBIYWZ1NGItblpDbng1YUdHOVljNDRidHZqWnR4X00wdGV3Y3JJdVJVcGQ3U0JfWU1XVHdaWS1KZlVsSG9j?oc=5","date":"2022-01-27","type":"regulatory","source":"DCAT Value Chain Insights","summary":"New Drug Approvals in 2021: The Numbers and Trends - DCAT Value Chain Insights","headline":"New Drug Approvals in 2021: The Numbers and Trends","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFBiQ3FPWXd0WE9GRGVIOERjdDZuelBXNVRhdjAtNTM0Y0k5VW9NeWt4Y2F3TnpORXdpTmloY0tPOHcySkpZbkZuNkx6NVpPcEUzdUpGYXJzVENFQW5qYnAwcjRYYzZYc2Y0?oc=5","date":"2016-07-08","type":"pipeline","source":"Zacks Investment Research","summary":"ASND: Ascendis Pharma - Full Company Report - Zacks Investment Research","headline":"ASND: Ascendis Pharma - Full Company Report","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}